Stephan Ludwig (André Schreiber)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Molecular Dynamics Simulations

Pseudomonas Aeruginosa

Tyrosine Kinase

Top Venues

Cellular and molecular life sciences : CMLS

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

André Schreiber, Dorothee Viemann, Jennifer Schöning, Sebastian Schloer, Angeles Mecate Zambrano, Linda Brunotte, Aileen Faist, Michael Schöfbänker, Eike Hrincius, Helen Hoffmann, Markus Hoffmann, Stefan Pöhlmann, Ursula Rescher, Oliver Planz, Stephan Ludwig
The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses. Cellular and molecular life sciences : CMLS 79 (1) (2022)
Stephan Ludwig, Benjamin Ambrosy, Oliver Planz, Sebastian Schloer, Ursula Rescher, Stephan Ludwig
The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs. Pharmaceutics 14 (9) (2022)
Stephan Ludwig, Laurita Boff, Darisuren Anhlan, Tim Krischuns, Linda Brunotte, Christian Schuberth, Roland Wedlich-Söldner, Hannes C A Drexler, Stephan Ludwig
Dissecting the mechanism of signaling-triggered nuclear export of newly synthesized influenza virus ribonucleoprotein complexes. Proceedings of the National Academy of Sciences of the United States of America 117 (28) (2020)
Angeles Mecate-Zambrano, Swathi Sukumar, Guiscard Seebohm, Kevin Ciminski, Stephan Ludwig, Darisuren Anhlan, Lilo Greune, Ludmilla Wixler, Stephanie Grothe, Nora Caroline Stein, M Alexander Schmidt, Klaus Langer, Martin Schwemmle, Tianlai Shi, Stephan Ludwig, Yvonne Boergeling
Discrete spatio-temporal regulation of tyrosine phosphorylation directs influenza A virus M1 protein towards its function in virion assembly. PLoS pathogens 16 (8) (2020)